Effects of Different General Anesthesia Methods on Immune Responses in Patients Undergoing Surgery for Tongue Cancer

NCT ID: NCT01854021

Last Updated: 2013-05-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Surgical excision is the mainstay of treatment for tongue cancer. However, surgery-induced immunosuppression has been implicated in the development of post-operative septic complications and neoplasm metastasis. General anesthesia is considered to not only suppress surgical stress, but also affect the immune function directly,such as altering the number and activity of immune cells. It is reported that some anesthetics increase susceptibility to tumor metastasis, apparently by suppressing natural killer cell activity. Different anesthetic techniques and anesthetics used in anesthesia have shown different effects on immunity. Many of the studies were animal trials or performed in vitro; in addition, most are focused on a single drug. To date, there is little published prospective clinical research designed specifically to investigate the effects of different general anesthetic technique on immune function in patients with oral malignant tumors. The aim of this study is going to characterize the immune response of patients undergoing surgery for tongue cancer under 3 types of general anesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tongue Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

inhalational anesthesia

inhalational anesthesia

Group Type EXPERIMENTAL

inhalational anesthesia

Intervention Type PROCEDURE

inhalational anesthesia

combined intravenous-inhalational anesthesia

combined intravenous-inhalational anesthesia

Group Type EXPERIMENTAL

combined intravenous-inhalational anesthesia

Intervention Type PROCEDURE

combined intravenous-inhalational anesthesia

intravenous anesthesia

intravenous anesthesia

Group Type EXPERIMENTAL

intravenous anesthesia

Intervention Type PROCEDURE

intravenous anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intravenous anesthesia

intravenous anesthesia

Intervention Type PROCEDURE

combined intravenous-inhalational anesthesia

combined intravenous-inhalational anesthesia

Intervention Type PROCEDURE

inhalational anesthesia

inhalational anesthesia

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All the patients were scheduled for elective surgery for tongue cancer under general anesthesia. None of the patients had a history of endocrine, immune and circulatory system diseases;

Exclusion Criteria

* contraindications for receiving chemotherapy,
* receiving perioperative blood transfusion, or
* preoperative and perioperative treatment with hormones and immunomodulatory agent.

Patients who suffered from any surgical complications such as infection were also excluded from our study.

\-
Minimum Eligible Age

50 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

tiejun Zhang

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

tiejun Zhang

Department of Anesthesiology , School and Hospital of Stomatology, Wuhan University

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

kebin Liu

Role: STUDY_DIRECTOR

Master of Department of Anesthesiology of Hospital of Stomatology, Wuhan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital of stomatology of wuhan university

Wuhan, Hubei, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

tiejun zhang, M.D.

Role: CONTACT

8602787686219

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

tiejun zhang, M.D.

Role: primary

8602787686219

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

wuhan university

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.